Cannibalism: A Biological and Evolutionary Perspective
Sounds of Science Podcast
Ubiquitin System: The Next Class of Drug Targets?
A Complex Role in Cellular Process & Growing Tool Set to Elucidate It
Bispecific Antibodies Close in on Cancer
Plotting Molecular Pincer Movements, Denying Cancer Room to Maneuver
Resolving Nonspecific Binding, Regeneration and Other Problems
For full access to this article login to GEN Select now.
RNAi Brings Analytical Value to Pharma R&D
Corroborative Studies and New Data Analysis Approaches Overcome Pervasive Drawbacks
- In the decade since the discovery of siRNA, the use of these molecules as therapeutics has received ample R&D investment and delivered a lot of promise. In the past two and a half months alone, several companies have reported positive clinical trial results for RNAi drug candidates. The ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.